7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Osteoarthritis, Hip D015207 4 associated lipids
Wounds and Injuries D014947 20 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Vision Disorders D014786 10 associated lipids
Vascular Diseases D014652 16 associated lipids
Urologic Neoplasms D014571 2 associated lipids
Uremia D014511 33 associated lipids
Tooth Resorption D014091 1 associated lipids
Tooth Mobility D014086 2 associated lipids
Tooth Migration D014085 2 associated lipids
Tinnitus D014012 4 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Thyroid Diseases D013959 8 associated lipids
Thinness D013851 11 associated lipids
Temporomandibular Joint Disorders D013705 4 associated lipids
Takayasu Arteritis D013625 3 associated lipids
Synovitis, Pigmented Villonodular D013586 1 associated lipids
Synovitis D013585 15 associated lipids
Stomatitis D013280 14 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Sclerosis D012598 5 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Osteosarcoma D012516 50 associated lipids
Sarcoma, Ewing D012512 2 associated lipids
Rupture, Spontaneous D012422 1 associated lipids
Root Resorption D012391 2 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Rheumatic Fever D012213 1 associated lipids
Radicular Cyst D011842 2 associated lipids
Prosthesis Failure D011475 1 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Progeria D011371 3 associated lipids
Prenatal Exposure Delayed Effects D011297 2 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Prediabetic State D011236 1 associated lipids
Polycythemia Vera D011087 13 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Periostitis D010522 1 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Periodontitis D010518 22 associated lipids
Periodontal Pocket D010514 9 associated lipids
Periodontal Diseases D010510 15 associated lipids
Familial Mediterranean Fever D010505 12 associated lipids
Pericardial Effusion D010490 2 associated lipids
Periapical Periodontitis D010485 6 associated lipids
Periapical Granuloma D010484 3 associated lipids
Periapical Diseases D010483 4 associated lipids
Paraneoplastic Syndromes D010257 4 associated lipids
Respirovirus Infections D010253 3 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Otosclerosis D010040 2 associated lipids
Osteosclerosis D010026 2 associated lipids
Osteoporosis D010024 12 associated lipids
Osteopetrosis D010022 1 associated lipids
Osteonecrosis D010020 5 associated lipids
Osteolysis, Essential D010015 1 associated lipids
Osteolysis D010014 8 associated lipids
Osteoarthritis D010003 4 associated lipids
Osteitis Deformans D010001 3 associated lipids
Osteitis D010000 10 associated lipids
Ossification, Heterotopic D009999 2 associated lipids
Obesity, Morbid D009767 8 associated lipids
Obesity D009765 29 associated lipids
Neuroblastoma D009447 66 associated lipids
Nerve Degeneration D009410 53 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Neoplastic Syndromes, Hereditary D009386 1 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Myocardial Infarction D009203 21 associated lipids
Cardiomyopathies D009202 10 associated lipids
Musculoskeletal Diseases D009140 2 associated lipids
Multiple Myeloma D009101 13 associated lipids
Mucocutaneous Lymph Node Syndrome D009080 9 associated lipids
Fluorosis, Dental D009050 1 associated lipids
Mitral Valve Stenosis D008946 3 associated lipids
Mitral Valve Insufficiency D008944 4 associated lipids
Measles D008457 3 associated lipids
Mandibular Injuries D008338 1 associated lipids
Mandibular Diseases D008336 5 associated lipids
Malocclusion, Angle Class I D008311 1 associated lipids
Malocclusion D008310 3 associated lipids
Macular Degeneration D008268 5 associated lipids
Lymphocytosis D008218 2 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Leukemia D007938 74 associated lipids
Legg-Calve-Perthes Disease D007873 1 associated lipids
Labyrinthitis D007762 2 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Kidney Diseases D007674 29 associated lipids
Jaw, Edentulous, Partially D007576 1 associated lipids
Jaw, Edentulous D007575 1 associated lipids
Jaw Diseases D007571 4 associated lipids
Insulin Resistance D007333 99 associated lipids
Inflammation D007249 119 associated lipids
Hypothyroidism D007037 32 associated lipids
Hypocalcemia D006996 12 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Sagar DR et al. Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. 2014 Ann. Rheum. Dis. pmid:23723320
Miller RE et al. RANKL inhibition blocks osteolytic lesions and reduces skeletal tumor burden in models of non-small-cell lung cancer bone metastases. 2014 J Thorac Oncol pmid:24496001
Akiyama T et al. Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain. 2014 J. Biol. Chem. pmid:24755218
Köttstorfer J et al. Are OPG and RANKL involved in human fracture healing? 2014 J. Orthop. Res. pmid:25212894
Jung Koo H et al. Effect of the combinatory mixture of Rubus coreanus Miquel and Astragalus membranaceus Bunge extracts on ovariectomy-induced osteoporosis in mice and anti-RANK signaling effect. 2014 J Ethnopharmacol pmid:24333364
Cianciolo G et al. Importance of vascular calcification in kidney transplant recipients. 2014 Am. J. Nephrol. pmid:24819032
Shao X et al. Metformin rescues the MG63 osteoblasts against the effect of high glucose on proliferation. 2014 J Diabetes Res pmid:24812633
Navratilova Z et al. Osteoprotegerin gene polymorphism is not associated with prosthetic joint infection after total joint arthroplasty in the Czech population. 2014 Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub pmid:22660233
Marques EA et al. Response of bone mineral density, inflammatory cytokines, and biochemical bone markers to a 32-week combined loading exercise programme in older men and women. 2013 Sep-Oct Arch Gerontol Geriatr pmid:23623588
Liu S et al. Association between g.19163A>G and g.23298T>C genetic variants of the osteoprotegerin gene and bone mineral density in Chinese women. 2013 Oct-Dec Hormones (Athens) pmid:24457406
Chiang PH et al. Zoledronic acid treatment for cancerous bone metastases: a phase IV study in Taiwan. 2013 Oct-Dec J Cancer Res Ther pmid:24518712
Canto-Cetina T et al. Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. 2013 Nov-Dec Am. J. Hum. Biol. pmid:24130145
Horshuns'ka MIu et al. [Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus]. 2013 May-Jun Ukr Biokhim Zh (1999) pmid:23937044
Zamora PO et al. Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis. 2013 Mar-Apr Int. J. Toxicol. pmid:23422080
Esteghamati A et al. Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23877020
Glintborg D et al. Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23211475
Nanjundaiah SM et al. Kinetics and interplay of mediators of inflammation-induced bone damage in the course of adjuvant arthritis. 2013 Jan-Mar Int J Immunopathol Pharmacol pmid:23527707
Wang ST et al. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria. 2013 Clin. Nephrol. pmid:23073066
Honma M et al. RANKL subcellular trafficking and regulatory mechanisms in osteocytes. 2013 J. Bone Miner. Res. pmid:23529793
Vinholt PJ et al. An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma. 2013 Thromb. Res. pmid:23531238
Shang M et al. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women. 2013 Clin. Biochem. pmid:23531404
Jin J et al. Risedronate inhibits bone marrow mesenchymal stem cell adipogenesis and switches RANKL/OPG ratio to impair osteoclast differentiation. 2013 J. Surg. Res. pmid:22487394
Janda K et al. Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis. 2013 Pol. Arch. Med. Wewn. pmid:23535831
Zhan X et al. Storage media enhance osteoclastogenic potential of human periodontal ligament cells via RANKL-independent signaling. 2013 Dent Traumatol pmid:22487464
Tripuwabhrut P et al. Effect of compressive force on human osteoblast-like cells and bone remodelling: an in vitro study. 2013 Arch. Oral Biol. pmid:23583016
Kadow-Romacker A et al. Effect of β-tricalcium phosphate coated with zoledronic acid on human osteoblasts and human osteoclasts in vitro. 2013 J Biomater Appl pmid:21862509
Marshall AJ et al. Long-chain triazolyl acids as inhibitors of osteoclastogenesis. 2013 Bioorg. Med. Chem. pmid:23726411
Brzóska MM and Rogalska J Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats. 2013 Toxicol. Appl. Pharmacol. pmid:23726800
Kim J et al. Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis. 2013 Clin. Biochem. pmid:23726804
Saini V et al. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. 2013 J. Biol. Chem. pmid:23729679
Wan S Editorial comment: The end of all our exploring ... 2013 Eur J Cardiothorac Surg pmid:23729753
Recht M et al. The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption. 2013 Haemophilia pmid:23731369
Wu X et al. Screening of osteoprotegerin-related feature genes in osteoporosis and functional analysis with DNA microarray. 2013 Eur. J. Med. Res. pmid:23731710
Rozas Moreno P et al. Serum osteoprotegerin: bone or cardiovascular marker in Type 2 diabetes males? 2013 J. Endocrinol. Invest. pmid:22391059
Koufany M et al. The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway. 2013 Arthritis Rheum. pmid:23982996
Mozzati M et al. Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid. 2013 Clin Oral Investig pmid:22864527
Ma XN et al. [Mechanisms of icariin in regulating bone formation of osteoblasts and bone resorption of osteoclasts]. 2013 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:23987492
Naumnik B et al. Age and gender predict OPG level and OPG/sRANKL ratio in maintenance hemodialysis patients. 2013 Adv Med Sci pmid:23959668
Belibasakis GN et al. The receptor activator of NF-κB ligand-osteoprotegerin system in pulpal and periapical disease. 2013 Int Endod J pmid:22900632
Kim SD et al. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. 2013 Biochem. Pharmacol. pmid:23928189
Crosley LK et al. The single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene influences endothelial cell function: interaction with selenium and fatty acids. 2013 Mol Nutr Food Res pmid:23934705
Zhang J et al. Feeding blueberry diets to young rats dose-dependently inhibits bone resorption through suppression of RANKL in stromal cells. 2013 PLoS ONE pmid:23936431
Thormann U et al. Bone formation induced by strontium modified calcium phosphate cement in critical-size metaphyseal fracture defects in ovariectomized rats. 2013 Biomaterials pmid:23906515
Lekesiz K et al. Effect of unfractionated heparin, enoxaparin and sulodexide on the relations between secretion and expression of OPG, RANKL and vWF in HUVEC. 2013 Folia Histochem. Cytobiol. pmid:23907946
Briana DD et al. Relationships between maternal novel adipocytokines and bone biomarkers in complicated by gestational hypertensive disorders and normal pregnancies. 2013 J. Matern. Fetal. Neonatal. Med. pmid:23406471
Enhos S et al. OPG and RANKL levels around miniscrew implants during orthodontic tooth movement. 2013 Am J Orthod Dentofacial Orthop pmid:23910201
McDonald MM et al. Matrix metalloproteinase-driven endochondral fracture union proceeds independently of osteoclast activity. 2013 J. Bone Miner. Res. pmid:23408642
Callegari A et al. Bone marrow- or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification. 2013 Arterioscler. Thromb. Vasc. Biol. pmid:23990207
Oshita K et al. [Regulation of osteoclastogenesis by human mesenchymal stem cells leading to application of a novel treatment for rheumatoid arthritis]. 2013 J. UOEH pmid:23475022
Kress DC Invited commentary. 2013 Ann. Thorac. Surg. pmid:23992687
Mozzanega B et al. Cyclic variations of bone resorption mediators and markers in the different phases of the menstrual cycle. 2013 J. Bone Miner. Metab. pmid:23479185
de Matos FR et al. Immunohistochemical detection of receptor activator nuclear κB ligand and osteoprotegerin in odontogenic cysts and tumors. 2013 J. Oral Maxillofac. Surg. pmid:23992784
Calderín S et al. Short-term clinical and osteoimmunological effects of scaling and root planing complemented by simple or repeated laser phototherapy in chronic periodontitis. 2013 Lasers Med Sci pmid:22546942
Yano S et al. Static and dynamic hypergravity responses of osteoblasts and osteoclasts in medaka scales. 2013 Zool. Sci. pmid:23480382
Yabumoto T et al. Stabilization of tooth movement by administration of reveromycin A to osteoprotegerin-deficient knockout mice. 2013 Am J Orthod Dentofacial Orthop pmid:23992809
Ghaffari S et al. The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography. 2013 Cardiol J pmid:23788300
Steagall WK et al. Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. 2013 Am. J. Pathol. pmid:23867796
Anastasilakis AD et al. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. 2013 J. Clin. Endocrinol. Metab. pmid:23788684
Welldon KJ et al. Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. 2013 Mol. Cell. Endocrinol. pmid:23791847
Aranha AM et al. Evidence supporting a protective role for th9 and th22 cytokines in human and experimental periapical lesions. 2013 J Endod pmid:23228262
Ding CZ et al. [Effects of zhengqing fengtongning tablet and methotrexate on the serum OPG/RANKL and IL-17 of collagen-induced arthritis rats]. 2013 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:23646485
Wang XF et al. The role of the serum RANKL/OPG ratio in the healing of intertrochanteric fractures in elderly patients. 2013 Mol Med Rep pmid:23440406
Jiang S et al. Changes of blood parameters associated with bone remodeling following experimentally induced fatty liver disorder in laying hens. 2013 Poult. Sci. pmid:23687138
Srivastava S et al. Assessment of the role of flavonoids for inducing osteoblast differentiation in isolated mouse bone marrow derived mesenchymal stem cells. 2013 Phytomedicine pmid:23570998
Fu YX et al. Influence of osteoprotegerin on differentiation, activation, and apoptosis of Gaoyou duck embryo osteoclasts in vitro. 2013 Poult. Sci. pmid:23687158
Lou Z et al. Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone. 2013 Med. Oncol. pmid:23690270
Suliburska J et al. The association of insulin resistance with serum osteoprotegerin in obese adolescents. 2013 J. Physiol. Biochem. pmid:23695991
Kato R et al. Gap-junction-mediated communication in human periodontal ligament cells. 2013 J. Dent. Res. pmid:23677649
Weng CH et al. [Effects of shangke jiegu tablet on the gene expressions of osteoprotegerin and osteoprotegerin ligand in the repairing process of mandibular defect rabbits]. 2013 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:23596799
Tetè S et al. Maxillary sinus augmentation procedures through equine-derived biomaterial or calvaria autologous bone: immunohistochemical evaluation of OPG/RANKL in humans. 2013 Eur J Histochem pmid:23549459
Matsuzaki E et al. Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines. 2013 Bone pmid:23612487
Brown TT et al. Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals. 2013 J. Acquir. Immune Defic. Syndr. pmid:23591634
Hyseni A et al. Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patients. 2013 Thromb. Res. pmid:23273402
Feng X et al. Modulatory effect of 1,25-dihydroxyvitamin D 3 on IL1 β -induced RANKL, OPG, TNF α , and IL-6 expression in human rheumatoid synoviocyte MH7A. 2013 Clin. Dev. Immunol. pmid:24348674
Engvall IL et al. Low-dose prednisolone in early rheumatoid arthritis inhibits collagen type I degradation by matrix metalloproteinases as assessed by serum 1CTP--a possible mechanism for specific inhibition of radiological destruction. 2013 Rheumatology (Oxford) pmid:23275387
Levidou G et al. TRAIL and osteoprotegerin (OPG) expression in bladder urothelial carcinoma: correlation with clinicopathological parameters and prognosis. 2013 Pathology pmid:23277172
de Moraes M et al. Immunoexpression of RANK, RANKL, OPG, VEGF, and vWF in radicular and dentigerous cysts. 2013 J. Oral Pathol. Med. pmid:23278112
Peris P et al. Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women. 2013 Mayo Clin. Proc. pmid:23228561
Liu CG et al. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro]. 2013 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:24517065
Zhang W et al. IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis. 2013 Inflammation pmid:22945280
Dieckmann M et al. Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo. 2013 J. Bone Miner. Res. pmid:22991192
Owen S et al. Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. 2013 Anticancer Res. pmid:23267146
Lazzerini PE et al. Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 2013 Joint Bone Spine pmid:22999910
Ambroszkiewicz J et al. Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis. 2013 Adv Med Sci pmid:24277958
Shao B et al. [RANKL and OPG expression in bone marrow-derived mesenchymal stem cells of ovariectomied promotes osteoclast development and enhances its function]. 2013 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi pmid:24321069
Jiang H et al. A randomized controlled trial of pre-conception treatment for periodontal disease to improve periodontal status during pregnancy and birth outcomes. 2013 BMC Pregnancy Childbirth pmid:24321402
Naranjo-Suarez S et al. Regulation of HIF-1α activity by overexpression of thioredoxin is independent of thioredoxin reductase status. 2013 Mol. Cells pmid:23912593
Dorotheou D et al. Tooth eruption: altered gene expression in the dental follicle of patients with cleidocranial dysplasia. 2013 Orthod Craniofac Res pmid:23311656
Zhang J et al. Occlusal effects on longitudinal bone alterations of the temporomandibular joint. 2013 J. Dent. Res. pmid:23340211
Feng ZY et al. Osteoprotegerin promotes the proliferation of chondrocytes and affects the expression of ADAMTS-5 and TIMP-4 through MEK/ERK signaling. 2013 Mol Med Rep pmid:24126801
Yang B et al. Effect of radiation on the Notch signaling pathway in osteoblasts. 2013 Int. J. Mol. Med. pmid:23340672
Wang X et al. Effect of osteoprotegerin in combination with interleukin-6 on inhibition of osteoclast differentiation. 2013 Chin. J. Traumatol. pmid:24103822
Lotinun S et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. 2013 J. Clin. Invest. pmid:23321671
Saki F et al. Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation. 2013 J. Bone Miner. Res. pmid:23322328
Srivastava S et al. Role of vanadium (V) in the differentiation of C3H10t1/2 cells towards osteoblast lineage: a comparative analysis with other trace elements. 2013 Biol Trace Elem Res pmid:23325289
Osorio A et al. Biochemical markers of vascular calcification in elderly hemodialysis patients. 2013 Mol. Cell. Biochem. pmid:23124853
Kim HS et al. The flavonoid glabridin attenuates 2-deoxy-D-ribose-induced oxidative damage and cellular dysfunction in MC3T3-E1 osteoblastic cells. 2013 Int. J. Mol. Med. pmid:23128413
Mogelvang R et al. Osteoprotegerin improves risk detection by traditional cardiovascular risk factors and hsCRP. 2013 Heart pmid:23135978
Ciccone MM et al. Serum osteoprotegerin and carotid intima-media thickness in acute/chronic coronary artery diseases. 2013 J Cardiovasc Med (Hagerstown) pmid:22772598
Wolf M et al. Potential role of high mobility group box protein 1 and intermittent PTH (1-34) in periodontal tissue repair following orthodontic tooth movement in rats. 2013 Clin Oral Investig pmid:22777389

Table of Content